PYPL vs RIGL · P/E 7.9, rev $33.17B vs P/E 9.1, rev $179.3M
PayPal Holdings Inc (PYPL) versus Rigel Pharmaceuticals Inc (RIGL) — a side-by-side from cached financials, not a winner call.
PayPal Holdings Inc (PYPL) is a credit services company listed on NASDAQ. It is led by Alex Chriss.
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
Latest reported PYPL revenue for 2025-12-31 was $33.17B. Net income was $5.23B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. PYPL currently screens at market cap $37.12B and trailing P/E 7.9.
Latest reported RIGL revenue for 2024-12-31 was $179.3M. Net income was $17.5M. Revenue was up 53.4% from 2023-12-31 to 2024-12-31. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
PYPL currently screens at market cap $37.12B and trailing P/E 7.9. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Not investment advice. Open the PYPL and RIGL stock pages for the full models.
Not investment advice.